Surge in Chikungunya Cases Among UK Travellers
Between January and June 2025, 73 cases were reported compared with 27 in the same period in 2024 – the highest number recorded for this timeframe. The majority were linked to travel to Sri Lanka, India, and Mauritius, where local outbreaks are ongoing. Most of the reported cases were in London.
For the first time, cases of Oropouche virus were also confirmed in UK travellers. All were linked to travel to Brazil.
Other Travel-Associated Infections
The UKHSA report — Travel-Associated Infections in England, Wales and Northern Ireland: January to June 2025— also found:
Cholera: Eight cases reported, compared with one in 2024. Most had travelled to India and Ethiopia, with all Ethiopia-linked cases tied to an outbreak there.
Meningococcal disease (MenW): Cases linked to travel to Saudi Arabia for Umrah and Hajj, and to household contacts of returning travellers.
Dengue: Cases fell by 67% to 161, compared with 490 last year.
Zika virus: Four cases reported, down from nine in 2024.
Chikungunya Outbreaks Widen
Chikungunya is a mosquito-borne viral infection found mainly in Africa and Asia, with cases also reported in parts of Europe and North America.
This year, large outbreaks have been seen in the Americas and Asia, with notable surges in China and on the Indian Ocean islands of Réunion, Mayotte, and Mauritius.
'We're seeing a worrying increase in cases among travellers returning to the UK,' said Dr Philip Veal, consultant in public health at UKHSA. He described chikungunya as a 'nasty' disease that, while rarely fatal, can cause severe joint and muscle pain, headaches, sensitivity to light, and skin rashes. Symptoms usually resolve within weeks, but joint pain can persist for months or years. Up to 12% of patients still experience discomfort 3 years after infection.
UKHSA stressed that the mosquitoes which transmit chikungunya are not established in the UK due to the climate, so there is currently no risk of local transmission. The agency said there is 'no risk of onward transmission of chikungunya in the UK'.
Oropouche Virus on the Rise
Oropouche virus is spread mainly by midge bites. Since 2024, infections have increased across South America, Central America, and the Caribbean, with Brazil seeing the largest outbreaks.
The species of midge responsible for transmission in the Americas is not found in the UK or Europe.
The disease often starts suddenly, with fever, chills, headache, joint pain, and muscle aches. Symptoms typically last up to 7 days, though in some cases it can cause meningitis or encephalitis.
The UKHSA has advised pregnant travellers to take particular care due to recent concerns about infection during pregnancy.
Preventative Measures
"It is essential to take precautions against mosquito bites when travelling,' said Veal. Measures include using insect repellent, covering exposed skin, and sleeping under insecticide-treated nets.
Travellers to high-risk areas may also consider vaccination. Two chikungunya vaccines have recently been approved for UK use, based on Joint Committee on Vaccination and Immunisation advice. They are available privately through travel clinics after assessment by a healthcare professional.
The UKHSA also reminded travellers to Saudi Arabia for pilgrimage to ensure they are vaccinated with the MenACWY vaccine before departure.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Legionnaires' disease cluster in New York City causes a 4th death, sickens over 100 people. What is it, and how do you get it?
NYC health officials identified the buildings connected to the outbreak, one being Harlem Hospital. A fourth person has died, and over 100 people have been sickened with Legionnaires' disease — 15 of them currently hospitalized — amid an outbreak in central Harlem in New York City, health officials said Thursday. The disease was initially detected on July 25. Since then, the New York City Department of Health has been investigating the cluster and linked it to 12 cooling towers in 10 Harlem buildings. Cooling towers are structures containing water and a fan that are used to regulate a building's temperature. Eleven of the 12 cooling towers that tested positive for the bacteria that cause Legionnaires' disease have been remediated, with the last one currently undergoing remediation, acting Health Commissioner Michelle Morse said during a Thursday news conference. Health officials released a list on Thursday that identifies the 10 buildings connected to the outbreak: BRP Companies, Lafayette Development LLC, 2239 Adam Clayton Powell Jr. Blvd. BVK, 215 W. 125th St. Commonwealth Local Development, 301 W. 124th St. CUNY — City College Marshak Science Building, 181 Convent Ave. Harlem Center Condo, 317 Lenox Ave. NYC Economic Development Corporation, 40 W. 137th St. NYC Health Department Central Harlem Sexual Health Clinic, 2238 Fifth Ave. NYC Health + Hospitals/Harlem, 506 Lenox Ave. The New York Hotel Trades Council Harlem Health Center, 133 Morningside Ave. Wharton Properties, 100 W. 125th St. (three of eight towers) Overall, the following ZIP codes have been affected in Harlem: 10027, 10030, 10035, 10037 and 10039. 'We are continuing to urge all New Yorkers who live or work in the identified ZIP codes in central Harlem who have flu-like symptoms to contact a health care provider immediately,' Morse said. 'New Yorkers should know the air is safe to breathe, and we are seeing declining numbers of new cases each day,' New York City Mayor Eric Adams told the media. 'I want to thank the health workers who worked tirelessly to treat this community and make sure its residents are healthy.' What is Legionnaires' disease? It's a serious type of pneumonia, a lung infection, that is caused by Legionella bacteria. People can become sick from inhaling water vapor that's contaminated with Legionella bacteria. Less commonly, a person can get sick when water contaminated with the bacteria accidentally enters the lungs by aspiration. How does it spread? In general, Legionnaires' is not transmitted from person to person. Legionella can grow and spread in human-made water systems like showerheads and sink faucets, hot tubs, decorative fountains, complex and large plumbing systems and cooling towers, according to the Centers for Disease Control and Prevention. There are also factors that make it easier for Legionella to grow and survive in water, including: Biofilm, which is slime that enables germs to grow Temperatures from 77 degrees to 113 degrees Fahrenheit Not having enough disinfectant Slow or no water movement (read more from the CDC about how to prevent waterborne germs while away from your home) What are the symptoms of Legionnaires' disease? Symptoms usually appear in a person within two to 14 days after they've been exposed to the bacteria, the CDC says. Symptoms can be similar to other types of pneumonia, such as: Headache Muscle aches Shortness of breath Cough Fever Other symptoms can include confusion, diarrhea or nausea. Who is at risk of getting sick? Most healthy people exposed to Legionella don't become ill, according to the CDC's website. However, the following people are at increased risk of getting sick from the bacteria: People 50 years and older Current or former smokers People with specific health issues or conditions, like cancer, chronic lung disease, diabetes, kidney failure, liver failure and a weak immune system Diagnosis and treatment A chest X-ray can confirm if a person has pneumonia. But additional tests are needed to confirm if Legionella bacteria is the cause behind it, such as a urine test, or a lab test involving a sample from phlegm (sputum) or lung lavage (lung washing), according to the CDC. The disease is treatable with antibiotics, but hospital care is often needed.
CBS News
29 minutes ago
- CBS News
Meat, dairy allergies from tick bites "skyrocketing" on Martha's Vineyard, expert says
There's a new medical issue on Martha's Vineyard, and it's impacting the way people eat. It's known as "alpha-gal syndrome," and is not a tick-borne illness, but rather an allergy in response to a tick bite. "It's skyrocketing across the island," explained Patrick Roden-Reynolds, a biologist and tick researcher on Martha's Vineyard. The allergy can come in response to a bite from a Lone Star tick, which are common in the south but have recently shown up in large numbers on the Vineyard - due to a combination of climate and an unusually large deer population, experts say. "In the last 15 years, the Lone Star tick has gone from non-existent on the island to fully abundant and everywhere," Roden-Reynolds explained. "So, the way I've been explaining it, our public health burden with just deer ticks and Lyme disease was, you know, already here at our eyeballs, and now with the Lone Star tick and alpha-gal concerns, it's way above our head." The allergy can cause a range of symptoms up to serious anaphylaxis in response to eating or even being near mammal meat, dairy, and some mammal-related products inside medicine. "Alpha-gal syndrome has been so explosive on Martha's Vineyard that pretty much it comes up in every conversation that I have, ticks or alpha-gal syndrome, even without folks knowing what I do for work," explained Lea Hamner, an epidemiologist on the island. Hamner provided WBZ with a graph that shows the increase in positive allergy testing on the island - from 32 in 2021 to more than 500 positive tests in 2024. There is still a lot to learn about the allergy, Hamner says, though one thing is known: people can go into remission, and an exacerbating force that makes the allergy worse is an increase in tick bites. "One thing that does influence whether you have a shot at remission is whether you stop getting tick bites," Hamner said. "More tick bites can send you back into allergy or keep you there. And so that's one of the really key things, is preventing more tick bites." How to prevent tick bites? According to experts: The prevalence of the allergy has changed the way restaurants are doing business. "Restaurants, food trucks, and other food establishments are including alpha-gal-friendly menu items on their menu," Roden-Reynolds explained. "Alpha-gal is now a selection you can choose on your list of allergies if you're ordering takeout, too."
Yahoo
2 hours ago
- Yahoo
Why Eli Lilly (LLY) Stock Is Up Today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.2% in the afternoon session after the stock extended its positive momentum partly fueled by reports of major insider buying by top executives, including the CEO, which is often seen as a strong vote of confidence. Additionally, news that the company has signed a multi-billion dollar deal with an AI health tech company (Superluminal) to discover and develop new obesity medicines also contributed to the positive sentiment. Finally, the company's decision to increase the price of its popular diabetes and weight-loss drug Mounjaro in the UK, in response to US political pressure, was also seen as a positive for future revenue. After the initial pop the shares cooled down to $705.51, up 3.1% from previous close. Is now the time to buy Eli Lilly? Access our full analysis report here, it's free. What Is The Market Telling Us Eli Lilly's shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 2 days ago when the stock gained 3.1% on the news that reports of significant insider buying by top executives, including the CEO, sent the stock rebounding from a recent selloff. The move came after regulatory filings on Tuesday revealed that several top executives, including CEO David Ricks, had purchased nearly $2.9 million worth of company stock. Ricks alone acquired over $1 million in shares, a move investors often interpret as a strong vote of confidence from leadership. This buying activity follows a significant selloff last week, where the stock dropped about 14% due to disappointing trial data for an oral obesity pill. The insider purchases are seen as a signal that management considers the stock undervalued after the recent decline and believes the market overreacted, providing a catalyst for Wednesday's rebound. Eli Lilly is down 9.3% since the beginning of the year, and at $705.51 per share, it is trading 26.5% below its 52-week high of $960.02 from August 2024. Investors who bought $1,000 worth of Eli Lilly's shares 5 years ago would now be looking at an investment worth $4,656. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
